EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Aberrant Methylation Inactivates Transforming Growth Factor β Receptor I in Head and Neck Squamous Cell Carcinoma

Teresita Muñoz-Antonia, Mariclara Torrellas-Ruiz, Jonathan Clavell, Linda A. Mathews, Carlos A. Muro-Cacho, Adriana Báez

International Journal of Otolaryngology · 2009

DOI: 10.1155/2009/848695 ↗
AbstractBibliografische Angaben

Abstract

Background . Alterations in TGF- β signaling are common in head and neck cancer (HNSCC). Mutations in TGF- β type II receptor ( T β R-II ) occur frequently in HNSCC while TGF- β type I receptor ( T β R-I ) mutations are rare, suggesting that other molecular alterations in the TGF- β pathway are likely. To identify abnormalities in T β R-I expression we analyzed 50 HNSCCs and correlated the results with clinical-pathologic features. Methods . Hypermethylation of T β R-I was evaluated via methylation-specific PCR (MSP) and restriction enzyme-mediated PCR (MSRE). Mutations in exons 1 and 7, mRNA and protein expression were analyzed by direct sequencing, semiquantitative RT—PCR and immunohistochemistry, respectively. Results. T β R-I expression was lost in 83% HNSCCs and was linked to DNA hypermethylation of the CpG-rich promoter region in 62% of the tumors. The variants 9A/6A and Int7G24A were found in two patients. Conclusions . This study shows that suppression of T β R-I expression in HNSCC is associated with DNA hypermethylation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →